Ellevest Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ellevest Inc’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15	Closed	-$1.64K	–	1837
2023 Q1	$1.64K	Buy	+15	New	+$1.66K	﹤0.01%	1485
2022 Q3	–	Sell	-406	Closed	-$32K	–	1982
2022 Q2	$32K	Sell	406 -326	-45%	-$30.9K	﹤0.01%	667
2022 Q1	$77K	Buy	732 +442	+152%	+$43.1K	0.01%	451
2021 Q4	$31K	Buy	290 +161	+125%	+$17.6K	﹤0.01%	629
2021 Q3	$14K	Buy	+129	New	+$13.4K	﹤0.01%	763

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ellevest Inc's HZNP Position: Q2 2023 in Review

Ellevest Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 15 shares — an estimated $1.64K sold.

Ellevest Inc first reported a position in HZNP in Q3 2021 and held it in 5 quarters. The position peaked at $77K in Q1 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Ellevest Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 15 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $1.64K.
Ellevest Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 5 quarters.
Ellevest Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $77K in Q1 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.